Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNS001 (methylphenidate) in adults with ADHD
NCT01323192Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Pharmaceutical. Started Mar 2011; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01323192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323192.